Jan 07, 2026
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs

On Tuesday, Amgen Inc. (NASDAQ:AMGN) acquired Dark Blue Therapeutics, a discovery and development biotech company focused on precision oncology medicines. The acquisition values Dark Blue Therapeutics at up to $840 million, including upfront and future milestones. Why Is The Acquisition…

Jan 07, 2026
CoStar Rolls Out $1.5 Billion Buyback, Targets Record EBITDA In 2026

CoStar Group, Inc. (NASDAQ:CSGP) on Wednesday outlined its key business, financial, and governance initiatives for 2026 and beyond. Also, the company approved a new $1.5 billion share repurchase program, following the accelerated completion of the $500 million buyback in 2025.…

Jan 07, 2026
Microsoft, Hexagon Put Humanoid Robots On Factory Floors

Microsoft Corporation (NASDAQ:MSFT) shares rose on Wednesday after it announced a robotics partnership. According to a release from measurement technologies firm Hexagon, the two companies will collaborate to accelerate the development of humanoid robots utilizing AI and cloud tools. Details…

Jan 07, 2026
Mobileye Pitches Robotaxis As Next Big Growth Vertical At CES

Mobileye Global Inc. (NASDAQ:MBLY) used its CES stage to widen its bet beyond driver assistance, unveiling a $900 million deal for Mentee Robotics that pushes the company into "physical AI" for industrial fleets. At the same time, the company framed…

Jan 07, 2026
Eli Lilly Shares Surge On Report Of Potential Ventyx Acquisition

Eli Lilly And Company (NYSE:LLY) shares are trading higher Wednesday following a report suggesting the company is nearing a deal for Ventyx Biosciences (NASDAQ:VTYX). Eli Lilly stock is charging ahead with explosive momentum. What’s driving LLY stock higher? What To…